Stay updated on Gilead Sciences Press Releases
Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.

Latest updates to the Gilead Sciences Press Releases page
- Check3 days agoChange DetectedThe news listing now includes an October 19 announcement about HIV and antiviral research at IDWeek 2026 and an October 15 notice about upcoming third-quarter financial results. The displayed release count increased from 1,981 to 1,983, while older August and July releases no longer appear in the list.SummaryDifference4%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedTwo new Newsroom entries dated September 16 and 15, 2026 were added (Lenacapavir HIV prevention updates and a PAHO partnership), and two older items were removed from the current feed (a Q2 2026 financial results release and a previously reported regimen study).SummaryDifference4%

- Check38 days agoChange DetectedAdded a News Release: 'Gilead Opens State-of-the-Art Research Center to Advance the Next Generation of Medicines' dated September 8, 2026. Removed the previously listed HIV research announcement, 'Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure' dated July 21, 2026, updating the newsroom lineup.SummaryDifference4%

- Check52 days agoChange DetectedThe Newsroom listing now includes two new items: an August 27, 2026 FDA approval for Bixlenvo and an August 26, 2026 notice about upcoming investor conferences; older June 2026 Trodelvy-related press releases have been removed from the listing.SummaryDifference4%

- Check59 days agoChange DetectedA new August 24, 2026 News Release on Trodelvy in first-line metastatic triple-negative breast cancer was added to the News Releases list, and the June 15, 2026 U.S. FDA acceptance of an investigational HIV prevention treatment was removed from the list.SummaryDifference4%

- Check73 days agoChange DetectedAdded a Newsroom entry for August 4, 2026 announcing Gilead Sciences' Second Quarter 2026 Financial Results. Removed the June 12, 2026 entry about rapid Remdesivir donation for Ebola relief from the Newsroom.SummaryDifference4%

Stay in the know with updates to Gilead Sciences Press Releases
Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.